Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Captain: Atorvastatin in Smokers With COPD
NCT04789057Phase 4Active, not recruiting
- Sponsor
- Medical University of Białystok
- Start
- Feb 2022
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of atorvastatin in chronic obstructive pulmonary disease (COPD), sponsored by Medical University of Białystok. Started Feb 2022; status: active, not recruiting.
02
Drugs
atorvastatin
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT04789057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04789057.